Bearss Medical Clinical Research is categorized under Medical Research in Tampa, FL and active since 2011.
Bearss Medical Clinical Research was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Ishola A Olabode at the company’s single location by writing to 2806 East Bearss Avenue, Tampa, Florida FL 33613 or by phoning (813) 977-7804. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Bearss Medical Clinical Research |
| Contact Person: | Ishola A Olabode |
| Address: | 2806 East Bearss Avenue, Tampa, Florida 33613 |
| Phone Number: | (813) 977-7804 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Bearss Medical Clinical Research was started in 2011 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Ishola A Olabode for inquiries that concern Bearss Medical Clinical Research by calling the company number (813) 977-7804, as your correspondence is most welcome. Additionally, the physical location of the single location of Bearss Medical Clinical Research can be found at the coordinates 28.080611,-82.427088 as well as the street address 2806 East Bearss Avenue in Tampa, Florida 33613.
For its online presence, you may visit Bearss Medical Clinical Research’s website at and engage with its social media outlets through on Twitter and on Facebook.